A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
Public ClinicalTrials.gov record NCT05593445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
Study identification
- NCT ID
- NCT05593445
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Ruxolitinib cream Drug
- Vehicle cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2022
- Primary completion
- Aug 31, 2023
- Completion
- Dec 20, 2023
- Last update posted
- Sep 23, 2024
2022 – 2023
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology | Birmingham | Alabama | 35244 | — |
| Mayo Clinic - Scottsdale | Scottsdale | Arizona | 85259 | — |
| UC Irvine | Irvine | California | 92697 | — |
| The Centers For Vulvovaginal Disorders | Washington D.C. | District of Columbia | 20037 | — |
| New Age Medical Research Corporation | Miami | Florida | 33186 | — |
| Circuit Clinical | West Seneca | New York | 14224 | — |
| Unc Dermatology and Skin Cancer Center At Southern Village | Chapel Hill | North Carolina | 27516 | — |
| Apex Dermatology | Ashtabula | Ohio | 44004 | — |
| Bexley Dermatology | Bexley | Ohio | 43209 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| University of Utah Health Care Midvalley Health Center Dermatology | Murray | Utah | 84107 | — |
| Seattle Skin and Laser Clinic | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05593445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05593445 live on ClinicalTrials.gov.